查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球显影剂剂注射器市场：按产品类型、按应用、按最终用户、按地区 - 预测至 2029 年
市场调查报告书
商品编码
1512223

全球显影剂剂注射器市场：按产品类型、按应用、按最终用户、按地区 - 预测至 2029 年

Contrast Media Injectors Market by Product (System, Consumable, Accessories), Type, Application, End user, & Region - Global Forecast to 2029
出版日期: | 出版商: MarketsandMarkets | 英文 200 Pages | 订单完成后即时交付

价格
简介目录

全球显影剂注射器市场规模预计将从2024年的16亿美元增加到2029年的23亿美元，2024年至2029年的复合年增长率为8.0%。

人口老化，加上癌症和心臟病的增加，对这些产品的需求不断增加。心血管疾病在老年族群中较为常见。显影剂有助于可视化血管并提高诊断可靠性。此外，显影剂导的手术的日益增长的益处正在推动对显影剂注射器的需求。

调查范围
调查年份 2022-2029
基准年 2023年
预测期 2024-2029
考虑单位 金额（美元）
按细分市场 按产品类型、按应用、按最终用户、按地区
目标区域 北美、欧洲、亚太地区、拉丁美洲、中东/非洲

依产品划分，显影剂注射器市场分为注射器系统、消耗品和配件。显影剂消耗品是用于管理诊断显影剂的各种产品，例如注射器、管子、管瓶/瓶子和静脉输液器。慢性病的增加和对早期诊断的需求导致诊断影像的增加，从而推动了对显影剂耗材的需求。

显影剂注射器市场按类型分为双头、单头和无注射器。心臟病患病率的上升和新兴国家商业机会的扩大正在推动这一领域的发展。中国有很多公司提供显影剂注射器和耗材。这些公司采取的专注于技术创新和扩大地理影响力的策略为整体市场成长提供了有利的机会。双头注射器具有显着的优点，例如提高工作流程效率和增强安全性。近年来，新型双头注射器的推出推动了最终用户设施的采用。

依应用划分，显影剂注射器市场分为介入性放射学、介入性心臟病学和放射学。放射科是主要细分市场，到2023年将占据显影剂注射器市场的最大份额。人口老化加剧导致慢性病发生率上升。这最终推动了显影剂注射器的采用。旨在早期发现症状的宣传活动的增加也有助于诊断影像扫描的增加，最终支持最终用户设施中采用显影剂。

依最终用户划分，显影剂注射器市场分为医院和诊断影像中心。到 2023 年，医院将占据最终用户市场占有率的大部分。对老年人群微创治疗的重视以及对安装先进诊断影像设备的津贴的增加正在推动显影剂输液设备融入医院环境。诊断成像中心数量的增加以满足对诊断成像设备不断增长的需求以及人口老化的持续增长预计将支持该领域的增长。

该报告研究了全球显影剂注射器市场，包括按产品类型、应用、最终用户、地区和参与市场的公司概况分類的趋势。

目录

第一章简介

第二章调查方法

第三章执行摘要

第 4 章重要考察

第五章市场概况

  • 介绍
  • 市场动态
  • 价值链分析
  • 供应链分析
  • 生态系分析
  • 监管分析
  • 退款场景
  • 投资金筹措场景
  • 价格分析
  • 贸易分析
  • 专利分析
  • 波特五力分析
  • 2024-2025年重大会议和活动
  • 案例研究分析
  • 技术分析
  • 影响客户业务的趋势/干扰
  • 主要相关人员和采购标准
  • 未满足的需求和主要问题
  • 显影剂剂注射器市场中的人工智慧 (AI)

第六章显影剂市场（依产品）

  • 介绍
  • 注射系统
  • 消耗品
  • 配件

第七章显影剂市场（按类型）

  • 介绍
  • 单头注射器
  • 双头注射器
  • 无注射器注射器

第八章显影剂市场（按应用）

  • 介绍
  • 放射科
  • 介入性心臟病学
  • 介入放射学

第 9 章显影剂注射器市场（按最终用户）

  • 介绍
  • 医院
  • 影像诊断中心

第10章显影剂市场（按地区）

  • 介绍
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第十一章竞争格局

  • 概述
  • 主要参与企业的策略/秘密
  • 收益分析
  • 市场占有率分析
  • 企业评估矩阵：主要参与企业，2023
  • 企业评估矩阵：Start-Ups/小型企业，2023 年
  • 公司评价及财务指标
  • 品牌/产品比较
  • 竞争场景

第十二章 公司简介

  • 主要参与企业
    • BAYER AG
    • BRACCO IMAGING SPA
    • GUERBET
    • ULRICH GMBH & CO. KG
    • MEDTRON AG
    • NEMOTO KYORINDO CO., LTD.
    • SHENZHEN ANKE HIGH-TECH CO., LTD.
    • SINO MDT
    • APOLLO RT CO., LTD.
    • SHENZHEN SEACROWN ELECTROMECHANICAL CO., LTD.
    • SHENZHEN ANTMED CO., LTD.
    • SHENZHEN LNKMED MEDICAL TECHNOLOGY CO., LTD.
    • UNION MEDICAL SHENZHEN CO., LTD.
    • SPECTRUM MEDICAL TECHNOLOGIES
    • SHENZHEN BOON MEDICAL SUPPLY CO., LTD.
  • 其他公司
    • SCW MEDICATH LTD.：COMPANY OVERVIEW
    • VYGON：COMPANY OVERVIEW
    • NANJING FOINOE CO., LTD.：COMPANY OVERVIEW
    • LEMER PAX：COMPANY OVERVIEW
    • COMECER SPA：COMPANY OVERVIEW
    • TEMA SINERGIE SPA：COMPANY OVERVIEW
    • SHEEN MAN CO., LTD.：COMPANY OVERVIEW
    • HONG KONG MEDI CO., LTD.：COMPANY OVERVIEW
    • QINGDAO HIPROVE MEDICAL TECHNOLOGIES CO., LTD.：COMPANY OVERVIEW
    • SHANGHAI KINDLY ENTERPRISE DEVELOPMENT GROUP CO., LTD：COMPANY OVERVIEW

第十三章附录

简介目录
Product Code: MD 5244

The global contrast media injectors market is expected to reach USD 2.3 billion by 2029 from USD 1.6 billion in 2024, at a CAGR of 8.0% from 2024 to 2029. Aging population, coupled with a rise in cancer and heart diseases, has increased the demand for these products. Cardiovascular diseases are more prevalent in old-age population. Contrast media helps to better visualize the blood vessels and improves diagnostic confidence. Moreover, increased benefits of contrast-mediated procedures have driven demand for contrast media injectors.

Scope of the Report
Years Considered for the Study2022-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD)
SegmentsBy Product, type, application, end user, and region
Regions coveredNorth America, Europe, Asia Pacific, Latin America, Middle East and Africa

"The consumables segment of product segment held the largest share of the market in 2023"

The contrast media injectors market is segmented based on product into injector systems, consumables, and accessories. Contrast media consumables, like - syringes, tubing, vials and bottles, IV sets, etc., are the various products used to administer contrast agents for imaging procedures. The rising prevalence of chronic diseases and the growing demand for early diagnosis have led to an increase in diagnostic imaging procedures, boosting the demand for contrast media consumables.

"The dual-head injector segment of type segment held the largest share of the market in 2023"

The contrast media injectors market is segmented based on type into dual-head, single head, syringeless. The rising prevalence of heart diseases and growing opportunities in emerging countries drives this segment. There are number of companies providing contrast media injectors and consumables in China. Focus on innovation and strategies adopted by these players to expand their geographic presence offers lucrative opportunity for the growth of overall market. Dual-head injectors have notable benefits such as improved workflow efficiency and enhanced safety. The launch of new dual-head injectors in past few years has supported its adoption in end user facilities.

"The radiology segment for application segment to hold the largest market share in 2023".

Based on application, the contrast media injectors market is segmented into interventional radiology, interventional cardiology, and radiology. Radiology was the major segment, accounting for the largest contrast media injectors market share in 2023. The rising incidence of chronic conditions is supported by the increasing aging population. This ultimately drives the adoption of contrast media injectors. A rising number of campaigns for the early detection of symptoms is also contributing to the increasing number of diagnostic imaging scans that ultimately support the adoption of contrast media injectors in end-user facilities.

"The diagnostic imaging centers segment for the end user segment is projected to register a significant CAGR during the forecast period."

The contrast media injectors market is segmented by end-users into hospitals and diagnostic imaging centers. The hospitals accounted for a major end-user market share in 2023. The emphasis on minimally invasive treatment among the old-age population and increasing grants for the installation of advanced imaging equipment are driving the integration of contrast media injectors into hospital settings. Rising number of diagnostic imaging centers to fulfill the growing demand for imaging equipment and consistent rise in old-age population is expected to support the growth of this segment.

"The market in the Asia Pacific region is expected to witness the highest growth during the forecast period."

Increased investment in healthcare infrastructure and services, especially in emerging economies, supports the expansion of diagnostic imaging and, consequently, the demand for contrast injectors. Key players in the market are focusing on expanding their presence in Asia Pacific market to cater the increasing demand for diagnostic scans. Moreover, the proliferation of diagnostic centers, particularly in APAC region, increases the availability and accessibility of imaging services, further driving the demand for contrast media injectors.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1-30%, Tier 2-42%, and Tier 3- 28%
  • By Designation: Director-level-10%, C-level-14%, and Others-76%
  • By Region: North America-40%, Europe-30%, Asia Pacific-22%, Latin America-6%, and the Middle East & Africa-2%

The prominent players in the contrast media injectors market are Bayer AG (Germany), Bracco Imaging S.p.A. (Italy), Guerbet (France), Medtron AG (Germany), Ulrich GmbH & Co. Kg (Germany), and Nemoto Kyorindo (Japan), Sino MDT (China)among others.

Research Coverage

This report studies the contrast media injectors market based on product, application, end user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will help market leaders and new entrants with information on the closest approximations of the revenue numbers for the overall contrast media injectors market and the subsegments. It will also help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.

This report provides insights on the following pointers:

  • Analysis of key drivers (increasing prevalence of cancer and cardiovascular diseases, growing adoption of contrast-mediated CT and MRI procedures, growing approvals of contrast media), restraints (high cost of contrast media injectors systems), opportunities (rising healthcare expenditure across emerging countries), and challenges (dearth of trained professionals) influencing the growth of the contrast media injectors market
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the contrast media injectors market
  • Market Development: Comprehensive information about lucrative markets-the report analyses the contrast media injectors market across varied regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the contrast media injectors market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players, such as Bayer AG (Germany), Guerbet (France), Bracco Imaging S.p.A. (Italy), Ulrich GmbH & Co. Kg (Germany), Medtron AG (Germany), and Nemoto Kyorindo (Japan).

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED
    • 1.3.3 CURRENCY CONSIDERED
  • 1.4 STAKEHOLDERS
  • 1.5 SUMMARY OF CHANGES
  • 1.6 RECESSION IMPACT

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 SECONDARY RESEARCH
    • 2.1.2 PRIMARY RESEARCH
      • 2.1.2.1 Primary sources
      • 2.1.2.2 Key industry insights
      • 2.1.2.3 Breakdown of primaries
    • FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
    • 2.2.1 BOTTOM-UP APPROACH
      • 2.2.1.1 Approach 1: Company revenue estimation approach
    • FIGURE 5 CONTRAST MEDIA INJECTORS MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ESTIMATION)
      • 2.2.1.2 Approach 2: Customer-based market estimation
    • FIGURE 6 CONTRAST MEDIA INJECTORS MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
      • 2.2.1.3 Growth forecast
      • 2.2.1.4 CAGR projections
    • FIGURE 7 CAGR PROJECTION: SUPPLY-SIDE ANALYSIS
  • 2.3 DATA TRIANGULATION METHODOLOGY
    • FIGURE 8 DATA TRIANGULATION METHODOLOGY
  • 2.4 RESEARCH LIMITATIONS
  • 2.5 MARKET SHARE ASSESSMENT
    • 2.5.1 STUDY ASSUMPTIONS
    • 2.5.2 GROWTH RATE ASSUMPTIONS
  • 2.6 RISK ASSESSMENT
    • TABLE 1 RISK ASSESSMENT ANALYSIS
  • 2.7 RECESSION IMPACT ANALYSIS

3 EXECUTIVE SUMMARY

    • FIGURE 9 CONTRAST MEDIA INJECTORS MARKET, PRODUCT, 2024 VS. 2029 (USD MILLION)
    • FIGURE 10 CONTRAST MEDIA INJECTORS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
    • FIGURE 11 CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
    • FIGURE 12 CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
    • FIGURE 13 GEOGRAPHIC SNAPSHOT OF CONTRAST MEDIA INJECTORS MARKET

4 PREMIUM INSIGHTS

  • 4.1 CONTRAST MEDIA INJECTORS MARKET OVERVIEW
    • FIGURE 14 GROWING ADOPTION OF CONTRAST-MEDIATED CT AND MRI DIAGNOSTIC PROCEDURES TO DRIVE MARKET
  • 4.2 NORTH AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT AND COUNTRY (2023)
    • FIGURE 15 CONSUMABLES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN US (2023)
  • 4.3 CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
    • FIGURE 16 INTERVENTIONAL CARDIOLOGY SEGMENT TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • 4.4 CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
    • FIGURE 17 DIAGNOSTIC IMAGING CENTERS SEGMENT TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
  • 4.5 CONTRAST MEDIA INJECTORS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 18 EMERGING MARKETS PROJECTED TO REACH HIGHER GROWTH RATES DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 19 CONTRAST MEDIA INJECTORS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising incidence of cancer and cardiovascular diseases
    • FIGURE 20 NEWLY DIAGNOSED CANCER CASES (MILLION)
    • TABLE 2 PROJECTED INCREASE IN GLOBAL NUMBER OF CANCER PATIENTS, 2020 VS. 2030 VS. 2040
      • 5.2.1.2 Increasing volume of contrast-mediated MRI and CT procedures
    • TABLE 3 NUMBER OF MRI EXAMS PERFORMED PER 1,000 INHABITANTS, BY COUNTRY, 2019-2021
    • TABLE 4 NUMBER OF CT EXAMS PERFORMED PER 1,000 INHABITANTS, BY COUNTRY, 2019-2021
      • 5.2.1.3 Growing approvals for CT and MRI contrast media to fuel demand for injectors
      • 5.2.1.4 Favorable reimbursements in developed markets
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High cost of contrast media injectors
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 High growth potential of emerging economies
      • 5.2.3.2 Growing focus on mammography and nuclear imaging injectors
      • 5.2.3.3 IT-enabled injector solutions
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Shortage of skilled professionals and limited technical expertise
  • 5.3 VALUE CHAIN ANALYSIS
    • 5.3.1 RESEARCH & DEVELOPMENT
    • 5.3.2 MANUFACTURING & ASSEMBLY
    • 5.3.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES
    • FIGURE 21 CONTRAST MEDIA INJECTORS MARKET: VALUE CHAIN ANALYSIS
  • 5.4 SUPPLY CHAIN ANALYSIS
    • 5.4.1 PROMINENT COMPANIES
    • 5.4.2 SMALL AND MEDIUM-SIZED ENTERPRISES
    • 5.4.3 END USERS
    • FIGURE 22 CONTRAST MEDIA INJECTORS MARKET: SUPPLY CHAIN ANALYSIS
  • 5.5 ECOSYSTEM ANALYSIS
    • FIGURE 23 PARENT MARKET: ECOSYSTEM ANALYSIS
    • TABLE 5 CONTRAST MEDIA INJECTORS MARKET: ROLE IN ECOSYSTEM
  • 5.6 REGULATORY ANALYSIS
    • TABLE 6 REGULATORY APPROVALS REQUIRED FOR CONTRAST MEDIA INJECTORS, BY COUNTRY
    • 5.6.1 REGULATORY BODIES AND GOVERNMENT AGENCIES
      • 5.6.1.1 North America: Regulatory bodies and government agencies
    • TABLE 7 NORTH AMERICA: LIST OF REGULATORY BODIES AND GOVERNMENT AGENCIES
      • 5.6.1.2 Europe: Regulatory bodies and government agencies
    • TABLE 8 EUROPE: LIST OF REGULATORY BODIES AND GOVERNMENT AGENCIES
      • 5.6.1.3 Asia Pacific: Regulatory bodies and government agencies
    • TABLE 9 ASIA PACIFIC: LIST OF REGULATORY BODIES AND GOVERNMENT AGENCIES
      • 5.6.1.4 Latin America: Regulatory bodies and government agencies
    • TABLE 10 LATIN AMERICA: LIST OF REGULATORY BODIES AND GOVERNMENT AGENCIES
      • 5.6.1.5 Middle East & Africa: Regulatory bodies and government agencies
    • TABLE 11 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES AND GOVERNMENT AGENCIES
    • 5.6.2 REGULATORY GUIDELINES
      • 5.6.2.1 US
    • TABLE 12 US FDA: MEDICAL DEVICE CLASSIFICATION
    • TABLE 13 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
    • FIGURE 24 PREMARKET NOTIFICATION: 510(K) APPROVALS FOR MEDICAL DEVICES
      • 5.6.2.2 Canada
    • TABLE 14 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
    • FIGURE 25 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES
      • 5.6.2.3 Europe
    • FIGURE 26 EUROPE: CE APPROVAL PROCESS FOR MEDICAL DEVICES
      • 5.6.2.4 Asia Pacific
        • 5.6.2.4.1 Japan
    • TABLE 15 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PHARMACEUTICAL AND MEDICAL DEVICE AGENCY (PMDA)
        • 5.6.2.4.2 China
    • TABLE 16 CHINA: CLASSIFICATION OF MEDICAL DEVICES
        • 5.6.2.4.3 India
        • 5.6.2.4.4 Brazil
  • 5.7 REIMBURSEMENT SCENARIO
    • TABLE 17 MEDICAL REIMBURSEMENT CODES FOR CONTRAST MEDIA IN US, 2023
  • 5.8 INVESTMENT & FUNDING SCENARIO
    • FIGURE 27 NUMBER OF DEALS & FUNDING INITIATIVES IN CONTRAST MEDIA INJECTORS MARKET, 2018-2022 (USD MILLION)
    • FIGURE 28 NUMBER OF INVESTOR DEALS IN CONTRAST MEDIA INJECTORS MARKET, BY KEY PLAYER, 2018-2022
    • FIGURE 29 VALUE OF INVESTOR DEALS IN CONTRAST MEDIA INJECTORS MARKET, BY KEY PLAYER, 2018-2022 (USD MILLION)
  • 5.9 PRICING ANALYSIS
    • FIGURE 30 AVERAGE SELLING PRICE TREND OF CONTRAST MEDIA INJECTORS, BY PRODUCT
    • FIGURE 31 AVERAGE SELLING PRICE TREND OF CONTRAST MEDIA INJECTORS, BY REGION
    • TABLE 18 AVERAGE SELLING PRICE OF CONTRAST MEDIA INJECTORS, BY REGION
  • 5.10 TRADE ANALYSIS
    • TABLE 19 IMPORT DATA FOR CONTRAST MEDIA INJECTORS (HS CODE 9018), BY COUNTRY, 2019-2023 (USD THOUSAND)
    • TABLE 20 EXPORT DATA FOR CONTRAST MEDIA INJECTORS (HS CODE 9018), BY COUNTRY, 2018-2022 (USD THOUSAND)
  • 5.11 PATENT ANALYSIS
    • FIGURE 32 PATENT ANALYSIS: CONTRAST MEDIA INJECTORS MARKET (2013-2023)
  • 5.12 PORTER'S FIVE FORCE ANALYSIS
    • TABLE 21 PORTER'S FIVE FORCES ANALYSIS: CONTRAST MEDIA INJECTORS MARKET
    • 5.12.1 THREAT OF NEW ENTRANTS
    • 5.12.2 THREAT OF SUBSTITUTES
    • 5.12.3 BARGAINING POWER OF SUPPLIERS
    • 5.12.4 BARGAINING POWER OF BUYERS
    • 5.12.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.13 KEY CONFERENCES & EVENTS IN 2024-2025
    • TABLE 22 LIST OF MAJOR CONFERENCES & EVENTS IN CONTRAST MEDIA INJECTORS MARKET, 2024-2025
  • 5.14 CASE STUDY ANALYSIS
    • TABLE 23 CASE STUDY 1: CARDIAC ENHANCEMENT ANALYSIS VIA CONTRAST MEDIA INJECTORS
  • 5.15 TECHNOLOGY ANALYSIS
    • 5.15.1 KEY TECHNOLOGIES
      • 5.15.1.1 MRI contrast media injectors
      • 5.15.1.2 CT contrast media injectors
      • 5.15.1.3 Angiography contrast media injectors
    • 5.15.2 COMPLEMENTARY TECHNOLOGIES
      • 5.15.2.1 Diagnostic imaging modalities
    • 5.15.3 ADJACENT TECHNOLOGIES
      • 5.15.3.1 Artificial intelligence with automated data systems
  • 5.16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
    • FIGURE 33 REVENUE SHIFT IN CONTRAST MEDIA INJECTORS MARKET
  • 5.17 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.17.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 34 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PRIMARY FACTORS
    • TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
    • FIGURE 35 BUYING CRITERIA FOR END USERS
    • TABLE 25 INFLUENCE OF END USERS ON BUYING PROCESS
    • FIGURE 36 INFLUENCE OF STAKEHOLDERS. BY END USER
    • TABLE 26 INFLUENCE OF STAKEHOLDERS, BY END USER
    • 5.17.2 BUYING CRITERIA
    • FIGURE 37 KEY BUYING CRITERIA FOR PROCESS CONTRAST MEDIA INJECTORS
    • TABLE 27 KEY BUYING CRITERIA FOR CONTRAST MEDIA INJECTORS
  • 5.18 UNMET NEEDS & KEY PAIN POINTS
    • TABLE 28 CONTRAST MEDIA INJECTORS MARKET: CURRENT UNMET NEEDS
  • 5.19 ARTIFICIAL INTELLIGENCE (AI) IN CONTRAST MEDIA INJECTORS MARKET

6 CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
    • TABLE 29 CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • 6.2 INJECTOR SYSTEMS
    • TABLE 30 CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 31 CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • 6.2.1 CT INJECTORS
      • 6.2.1.1 Increasing number of CT scans to boost demand
    • TABLE 32 CT INJECTORS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • 6.2.2 MRI INJECTORS
      • 6.2.2.1 Rising funding initiatives for development of advanced systems to propel market
    • TABLE 33 MRI INJECTORS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • 6.2.3 ANGIOGRAPHY INJECTORS
      • 6.2.3.1 High uptake of cardiac catheterization procedures to drive market
    • TABLE 34 ANGIOGRAPHY INJECTORS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • 6.2.4 OTHER INJECTORS
  • 6.3 CONSUMABLES
    • TABLE 35 CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 36 CONTRAST MEDIA CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • 6.3.1 SYRINGES
      • 6.3.1.1 Diverse size range to fuel uptake
    • TABLE 37 SYRINGES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • 6.3.2 TUBES
      • 6.3.2.1 Increasing demand for single-use products to drive market
    • TABLE 38 TUBES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • 6.3.3 OTHER CONSUMABLES
    • TABLE 39 OTHER CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • 6.4 ACCESSORIES
    • 6.4.1 ABILITY TO ENHANCE WORKFLOW EFFICIENCY TO SUPPORT MARKET GROWTH
    • TABLE 40 CONTRAST MEDIA ACCESSORIES MARKET, BY REGION, 2022-2029 (USD MILLION)

7 CONTRAST MEDIA INJECTORS MARKET, BY TYPE

  • 7.1 INTRODUCTION
    • TABLE 41 CONTRAST MEDIA INJECTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • 7.2 SINGLE-HEAD INJECTORS
    • 7.2.1 COST-EFFICIENT AND USER-FRIENDLY DESIGN TO PROPEL MARKET
    • TABLE 42 CONTRAST MEDIA INJECTORS MARKET FOR SINGLE-HEAD INJECTORS, BY REGION, 2022-2029 (USD MILLION)
  • 7.3 DUAL-HEAD INJECTORS
    • 7.3.1 PRECISE CONTROL AND ENHANCED PATIENT SAFETY TO BOOST DEMAND
    • TABLE 43 CONTRAST MEDIA INJECTORS MARKET FOR DUAL-HEAD INJECTORS, BY REGION, 2022-2029 (USD MILLION)
  • 7.4 SYRINGELESS INJECTORS
    • 7.4.1 DIRECT ADMINISTRATION VIA TUBING TO SUPPORT MARKET GROWTH
    • TABLE 44 CONTRAST MEDIA INJECTORS MARKET FOR SYRINGELESS INJECTORS, BY REGION, 2022-2029 (USD MILLION)

8 CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
    • TABLE 45 CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • 8.2 RADIOLOGY
    • 8.2.1 RISING NUMBER OF RADIOLOGY PROCEDURES TO DRIVE MARKET
    • TABLE 46 CONTRAST MEDIA INJECTORS MARKET FOR RADIOLOGY, BY REGION, 2022-2029 (USD MILLION)
  • 8.3 INTERVENTIONAL CARDIOLOGY
    • 8.3.1 RISING UPTAKE OF CORONARY CT ANGIOGRAMS TO PROPEL MARKET
    • TABLE 47 CONTRAST MEDIA INJECTORS MARKET FOR INTERVENTIONAL CARDIOLOGY, BY REGION, 2022-2029 (USD MILLION)
  • 8.4 INTERVENTIONAL RADIOLOGY
    • 8.4.1 INCREASING PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES TO SUPPORT MARKET GROWTH
    • TABLE 48 CONTRAST MEDIA INJECTORS MARKET FOR INTERVENTIONAL RADIOLOGY, BY REGION, 2022-2029 (USD MILLION)

9 CONTRAST MEDIA INJECTORS MARKET, BY END USER

  • 9.1 INTRODUCTION
    • TABLE 49 CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 9.2 HOSPITALS
    • 9.2.1 HIGH PURCHASING POWER FOR ADVANCED EQUIPMENT TO SUPPORT MARKET GROWTH
    • TABLE 50 CONTRAST MEDIA INJECTORS MARKET FOR HOSPITALS, BY REGION, 2022-2029 (USD MILLION)
  • 9.3 DIAGNOSTIC IMAGING CENTERS
    • 9.3.1 INCREASING ESTABLISHMENT OF PRIVATE IMAGING CENTERS TO PROPEL MARKET
    • TABLE 51 CONTRAST MEDIA INJECTORS MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY REGION, 2022-2029 (USD MILLION)

10 CONTRAST MEDIA INJECTORS MARKET, BY REGION

  • 10.1 INTRODUCTION
    • TABLE 52 CONTRAST MEDIA INJECTORS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • 10.2 NORTH AMERICA
    • FIGURE 38 NORTH AMERICA: CONTRAST MEDIA INJECTORS MARKET SNAPSHOT
    • TABLE 53 NORTH AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 54 NORTH AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 55 NORTH AMERICA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 56 NORTH AMERICA: CONTRAST MEDIA INJECTORS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 57 NORTH AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 58 NORTH AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 59 NORTH AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.2.1 NORTH AMERICA: RECESSION IMPACT
    • 10.2.2 US
      • 10.2.2.1 Rising adoption of technologically advanced products to drive market
    • TABLE 60 US: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 61 US: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 62 US: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • 10.2.3 CANADA
      • 10.2.3.1 Rising investments in medical imaging equipment to drive market
    • TABLE 63 CANADA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 64 CANADA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 65 CANADA: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • 10.3 EUROPE
    • TABLE 66 EUROPE: CONTRAST MEDIA INJECTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 67 EUROPE: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 68 EUROPE: CONTRAST MEDIA INJECTORS SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 69 EUROPE: CONTRAST MEDIA INJECTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 70 EUROPE: CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 71 EUROPE: CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.3.1 EUROPE: RECESSION IMPACT
    • 10.3.2 GERMANY
      • 10.3.2.1 Advancements in imaging technologies to fuel uptake
    • TABLE 72 GERMANY: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 73 GERMANY: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 74 GERMANY: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • 10.3.3 FRANCE
      • 10.3.3.1 Increasing prevalence of cancer to propel market
    • TABLE 75 FRANCE: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 76 FRANCE: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 77 FRANCE: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • 10.3.4 UK
      • 10.3.4.1 High incidence of CVD to propel market
    • TABLE 78 UK: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 79 UK: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 80 UK: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • 10.3.5 ITALY
      • 10.3.5.1 Rising incidence of chronic diseases to support market growth
    • TABLE 81 ITALY: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 82 ITALY: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 83 ITALY: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • 10.3.6 SPAIN
      • 10.3.6.1 Shortage of skilled radiologists to restrain market
    • TABLE 84 SPAIN: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 85 SPAIN: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 86 SPAIN: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • 10.3.7 REST OF EUROPE
    • TABLE 87 REST OF EUROPE: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 88 REST OF EUROPE: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 89 REST OF EUROPE: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • 10.4 ASIA PACIFIC
    • FIGURE 39 ASIA PACIFIC: CONTRAST MEDIA INJECTORS MARKET SNAPSHOT
    • TABLE 90 ASIA PACIFIC: CONTRAST MEDIA INJECTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 91 ASIA PACIFIC: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 92 ASIA PACIFIC: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 93 ASIA PACIFIC: CONTRAST MEDIA INJECTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 94 ASIA PACIFIC: CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 95 ASIA PACIFIC: CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.4.1 ASIA PACIFIC: RECESSION IMPACT
    • 10.4.2 JAPAN
      • 10.4.2.1 Rising geriatric population and subsequent increase in chronic diseases to drive market
    • TABLE 96 JAPAN: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 97 JAPAN: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 98 JAPAN: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • 10.4.3 CHINA
      • 10.4.3.1 Rising incidence of cancer and increasing establishment of hospitals to boost demand
    • TABLE 99 CHINA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 100 CHINA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 101 CHINA: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • 10.4.4 INDIA
      • 10.4.4.1 Growing investments in radiology to propel market
    • TABLE 102 INDIA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 103 INDIA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 104 INDIA: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • 10.4.5 AUSTRALIA
      • 10.4.5.1 Increasing R&D investments for advanced diagnostic modalities to drive market
    • TABLE 105 AUSTRALIA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 106 AUSTRALIA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 107 AUSTRALIA: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • 10.4.6 SOUTH KOREA
      • 10.4.6.1 Favorable reimbursements for diagnostic procedures to support market growth
    • TABLE 108 SOUTH KOREA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 109 SOUTH KOREA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 110 SOUTH KOREA: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • 10.4.7 REST OF ASIA PACIFIC
    • TABLE 111 REST OF ASIA PACIFIC: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 112 REST OF ASIA PACIFIC: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 113 REST OF ASIA PACIFIC: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • 10.5 LATIN AMERICA
    • TABLE 114 LATIN AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 115 LATIN AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 116 LATIN AMERICA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 117 LATIN AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 118 LATIN AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 119 LATIN AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.5.1 LATIN AMERICA: RECESSION IMPACT
    • 10.5.2 BRAZIL
      • 10.5.2.1 Growing awareness of early disease detection & diagnosis to drive market
    • TABLE 120 BRAZIL: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 121 BRAZIL: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 122 BRAZIL: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • 10.5.3 MEXICO
      • 10.5.3.1 Inadequate healthcare infrastructure to restrain market
    • TABLE 123 MEXICO: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 124 MEXICO: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 125 MEXICO: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • 10.5.4 REST OF LATIN AMERICA
    • TABLE 126 REST OF LATIN AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 127 REST OF LATIN AMERICA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 128 REST OF LATIN AMERICA: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • 10.6 MIDDLE EAST & AFRICA
    • 10.6.1 IMPROVEMENTS IN HEALTHCARE INFRASTRUCTURE TO DRIVE MARKET
    • TABLE 129 MIDDLE EAST & AFRICA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 130 MIDDLE EAST & AFRICA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 131 MIDDLE EAST & AFRICA: CONTRAST MEDIA INJECTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 132 MIDDLE EAST & AFRICA: CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 133 MIDDLE EAST & AFRICA: CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN CONTRAST MEDIA INJECTORS MARKET
    • TABLE 134 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES
  • 11.3 REVENUE ANALYSIS
    • FIGURE 40 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN CONTRAST MEDIA INJECTORS MARKET (2019-2023)
  • 11.4 MARKET SHARE ANALYSIS
    • FIGURE 41 MARKET SHARE ANALYSIS OF KEY PLAYERS (2023)
    • TABLE 135 CONTRAST MEDIA INJECTORS MARKET: DEGREE OF COMPETITION
    • 11.4.1 RANKING OF KEY MARKET PLAYERS
    • FIGURE 42 RANKING OF KEY PLAYERS IN CONTRAST MEDIA INJECTORS MARKET, 2023
  • 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 11.5.1 STARS
    • 11.5.2 EMERGING LEADERS
    • 11.5.3 PERVASIVE PLAYERS
    • 11.5.4 PARTICIPANTS
    • FIGURE 43 CONTRAST MEDIA INJECTORS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
    • 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 11.5.5.1 Company footprint
    • FIGURE 44 CONTRAST MEDIA INJECTORS MARKET: COMPANY FOOTPRINT
      • 11.5.5.2 Product footprint
    • TABLE 136 CONTRAST MEDIA INJECTORS MARKET: PRODUCT FOOTPRINT
      • 11.5.5.3 Application footprint
    • TABLE 137 CONTRAST MEDIA INJECTORS MARKET: APPLICATION FOOTPRINT
      • 11.5.5.4 End-user footprint
    • TABLE 138 CONTRAST MEDIA INJECTORS MARKET: END-USER FOOTPRINT
      • 11.5.5.5 Region footprint
    • TABLE 139 CONTRAST MEDIA INJECTORS MARKET: REGION FOOTPRINT
  • 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 11.6.1 PROGRESSIVE COMPANIES
    • 11.6.2 RESPONSIVE COMPANIES
    • 11.6.3 DYNAMIC COMPANIES
    • 11.6.4 STARTING BLOCKS
    • FIGURE 45 CONTRAST MEDIA INJECTORS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
    • 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
    • TABLE 140 CONTRAST MEDIA INJECTORS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
    • TABLE 141 CONTRAST MEDIA INJECTORS MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
  • 11.7 COMPANY VALUATION & FINANCIAL METRICS
    • 11.7.1 FINANCIAL METRICS
    • FIGURE 46 EV/EBITDA OF KEY VENDORS
    • 11.7.2 COMPANY VALUATION
    • FIGURE 47 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • 11.8 BRAND/PRODUCT COMPARISON
    • FIGURE 48 CONTRAST MEDIA INJECTORS MARKET: BRAND/PRODUCT COMPARISON ANALYSIS
  • 11.9 COMPETITIVE SCENARIO
    • 11.9.1 PRODUCT LAUNCHES & APPROVALS
    • TABLE 142 CONTRAST MEDIA INJECTORS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-MAY 2024
    • 11.9.2 DEALS
    • TABLE 143 CONTRAST MEDIA INJECTORS MARKET: DEALS, JANUARY 2021-MAY 2024
    • 11.9.3 EXPANSIONS
    • TABLE 144 CONTRAST MEDIA INJECTORS MARKET: EXPANSIONS, JANUARY 2021-MAY 2024

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
  • (Business overview, Products offered, Recent developments, MnM view, Key strengths, Strategic choices, and Weaknesses and Competitive threats)**
    • 12.1.1 BAYER AG
    • TABLE 145 BAYER AG: COMPANY OVERVIEW
    • FIGURE 49 BAYER AG: COMPANY SNAPSHOT (2023)
    • TABLE 146 BAYER AG: PRODUCTS OFFERED
    • TABLE 147 BAYER AG: DEALS, JANUARY 2021-MAY 2024
    • 12.1.2 BRACCO IMAGING S.P.A.
    • TABLE 148 BRACCO IMAGING S.P.A.: COMPANY OVERVIEW
    • TABLE 149 BRACCO IMAGING S.P.A.: PRODUCTS OFFERED
    • TABLE 150 BRACCO IMAGING S.P.A.: DEALS, JANUARY 2021-MAY 2024
    • TABLE 151 BRACCO IMAGING S.P.A.: EXPANSIONS, JANUARY 2021-MAY 2024
    • 12.1.3 GUERBET
    • TABLE 152 GUERBET: COMPANY OVERVIEW
    • FIGURE 50 GUERBET: COMPANY SNAPSHOT (2023)
    • TABLE 153 GUERBET: PRODUCTS OFFERED
    • TABLE 154 GUERBET: PRODUCT LAUNCHES, JANUARY 2021-MAY 2024
    • 12.1.4 ULRICH GMBH & CO. KG
    • TABLE 155 ULRICH GMBH & CO. KG: COMPANY OVERVIEW
    • TABLE 156 ULRICH GMBH & CO. KG: PRODUCTS OFFERED
    • TABLE 157 ULRICH GMBH & CO. KG: DEALS, JANUARY 2021-MAY 2024
    • 12.1.5 MEDTRON AG
    • TABLE 158 MEDTRON AG.: COMPANY OVERVIEW
    • TABLE 159 MEDTRON AG: PRODUCTS OFFERED
    • TABLE 160 MEDTRON AG: DEALS, JANUARY 2021-MAY 2024
    • 12.1.6 NEMOTO KYORINDO CO., LTD.
    • TABLE 161 NEMOTO KYORINDO CO., LTD.: COMPANY OVERVIEW
    • TABLE 162 NEMOTO KYORINDO CO., LTD.: PRODUCTS OFFERED
    • 12.1.7 SHENZHEN ANKE HIGH-TECH CO., LTD.
    • TABLE 163 SHENZHEN ANKE HIGH-TECH CO., LTD.: COMPANY OVERVIEW
    • TABLE 164 SHENZHEN ANKE HIGH-TECH CO., LTD.: PRODUCTS OFFERED
    • 12.1.8 SINO MDT
    • TABLE 165 SINO MDT: COMPANY OVERVIEW
    • TABLE 166 SINO MDT: PRODUCTS OFFERED
    • 12.1.9 APOLLO RT CO., LTD.
    • TABLE 167 APOLLO RT CO., LTD.: COMPANY OVERVIEW
    • TABLE 168 APOLLO RT CO., LTD.: PRODUCTS OFFERED
    • 12.1.10 SHENZHEN SEACROWN ELECTROMECHANICAL CO., LTD.
    • TABLE 169 SHENZHEN SEACROWN ELECTROMECHANICAL CO., LTD.: COMPANY OVERVIEW
    • TABLE 170 SHENZHEN SEACROWN ELECTROMECHANICAL CO., LTD.: PRODUCTS OFFERED
    • 12.1.11 SHENZHEN ANTMED CO., LTD.
    • TABLE 171 SHENZHEN ANTMED CO., LTD.: COMPANY OVERVIEW
    • TABLE 172 SHENZHEN ANTMED CO., LTD.: PRODUCTS OFFERED
    • 12.1.12 SHENZHEN LNKMED MEDICAL TECHNOLOGY CO., LTD.
    • TABLE 173 SHENZHEN LNKMED MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
    • TABLE 174 SHENZHEN LNKMED MEDICAL TECHNOLOGY CO., LTD.: PRODUCTS OFFERED
    • 12.1.13 UNION MEDICAL SHENZHEN CO., LTD.
    • TABLE 175 UNION MEDICAL SHENZHEN CO., LTD.: COMPANY OVERVIEW
    • TABLE 176 UNION MEDICAL SHENZHEN CO., LTD.: PRODUCTS OFFERED
    • 12.1.14 SPECTRUM MEDICAL TECHNOLOGIES
    • TABLE 177 SPECTRUM MEDICAL TECHNOLOGIES: COMPANY OVERVIEW
    • TABLE 178 SPECTRUM MEDICAL TECHNOLOGIES: PRODUCTS OFFERED
    • 12.1.15 SHENZHEN BOON MEDICAL SUPPLY CO., LTD.
    • TABLE 179 SHENZHEN BOON MEDICAL SUPPLY CO., LTD.: COMPANY OVERVIEW
    • TABLE 180 SHENZHEN BOON MEDICAL SUPPLY CO., LTD.: PRODUCTS OFFERED
  • 12.2 OTHER PLAYERS
    • 12.2.1 SCW MEDICATH LTD.: COMPANY OVERVIEW
    • 12.2.2 VYGON: COMPANY OVERVIEW
    • 12.2.3 NANJING FOINOE CO., LTD.: COMPANY OVERVIEW
    • 12.2.4 LEMER PAX: COMPANY OVERVIEW
    • 12.2.5 COMECER S.P.A.: COMPANY OVERVIEW
    • 12.2.6 TEMA SINERGIE S.P.A.: COMPANY OVERVIEW
    • 12.2.7 SHEEN MAN CO., LTD.: COMPANY OVERVIEW
    • 12.2.8 HONG KONG MEDI CO., LTD.: COMPANY OVERVIEW
    • 12.2.9 QINGDAO HIPROVE MEDICAL TECHNOLOGIES CO., LTD.: COMPANY OVERVIEW
    • 12.2.10 SHANGHAI KINDLY ENTERPRISE DEVELOPMENT GROUP CO., LTD: COMPANY OVERVIEW
  • *Details on Business overview, Products offered, Recent developments, MnM view, Key strengths, Strategic choices, and Weaknesses and Competitive threats might not be captured in case of unlisted companies.

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS